View Author
diaphragmatic hernia diaphragmatic hernia pediatr patient hypertension cdh survivors sildena fil treatment ventilation survivor sildena extracorporeal membrane oxygenation study infant auc 24 model neonate variability pharmacokinetic effect survival sil +dms therapy concentration problem clearance lung disease development factor oxygenation volume outcome morbidity strategy cdh patients disease function postnatal membrane hospital newborn ratio exposure extracorporeal research adult parameter inhaled nitric oxide predictor lung-to-head ratio follow-up desmethylsildena fil interpatient variability plasma population uconazole litre oxide nitric distribution pressure arch dis child covariate diaphragm ventilation strategies fi nal model interpatient fi rst year children fl uconazole use administration inhibitor repair desmethylsildena estimate growth surfactant 20 mg ultrasound
